Victory Capital Management
RGNX icon

Victory Capital Management’s Regenxbio RGNX Stock Holding History

Victory Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,286
Closed -$537K – 2479
2025
Q4 		$537K Buy
+37,286
New +$465K ﹤0.01% 2000
2023
Q2 		– Sell
-10,768
Closed -$204K – 2583
2023
Q1 		$204K Sell
10,768
-6,753
-39% -$149K ﹤0.01% 2243
2022
Q4 		$397K Sell
17,521
-15,231
-47% -$344K ﹤0.01% 2085
2022
Q3 		$866K Buy
32,752
+8,536
+35% +$253K ﹤0.01% 1801
2022
Q2 		$598K Buy
24,216
+9,992
+70% +$250K ﹤0.01% 1971
2022
Q1 		$395K Buy
+14,224
New +$395K ﹤0.01% 2213
2021
Q4 		– Sell
-4,794
Closed -$201K – 2834
2021
Q3 		$201K Buy
+4,794
New +$172K ﹤0.01% 2526
2020
Q2 		– Sell
-4,696
Closed -$152K – 3120
2020
Q1 		$152K Sell
4,696
-873
-16% -$36.4K ﹤0.01% 2223
2019
Q4 		$228K Buy
5,569
+687
+14% +$27.1K ﹤0.01% 2278
2019
Q3 		$174K Sell
4,882
-36,377
-88% -$1.47M ﹤0.01% 2263
2019
Q2 		$2.12M Sell
41,259
-2,620
-6% -$131K ﹤0.01% 1128
2019
Q1 		$2.52M Sell
43,879
-490
-1% -$24.3K 0.01% 1041
2018
Q4 		$1.86M Buy
44,369
+9,510
+27% +$558K ﹤0.01% 1056
2018
Q3 		$2.63M Sell
34,859
-28,750
-45% -$2.07M 0.01% 1045
2018
Q2 		$4.56M Sell
63,609
-3,550
-5% -$170K 0.01% 863
2018
Q1 		$2M Buy
67,159
+7,330
+12% +$213K ﹤0.01% 1069
2017
Q4 		$1.99M Buy
59,829
+11,300
+23% +$340K ﹤0.01% 1038
2017
Q3 		$1.6M Buy
48,529
+2,070
+4% +$46.6K ﹤0.01% 1082
2017
Q2 		$918K Sell
46,459
-510
-1% -$9.88K ﹤0.01% 1207
2017
Q1 		$907K Buy
46,969
+11,079
+31% +$214K ﹤0.01% 1200
2016
Q4 		$666K Sell
35,890
-12,960
-27% -$248K ﹤0.01% 1223
2016
Q3 		$684K Buy
+48,850
New +$539K ﹤0.01% 1158

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management's RGNX Position: Q1 2026 in Review

Victory Capital Management sold out of Regenxbio (RGNX) in Q1 2026, closing a stake of 37,286 shares — an estimated $537K sold.

Victory Capital Management first reported a position in RGNX in Q3 2016 and held it in 22 quarters. The position peaked at $4.56M in Q2 2018. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • Victory Capital Management reported no remaining Regenxbio position as of Q1 2026 after selling out during the quarter.
  • Victory Capital Management sold 37,286 Regenxbio shares in Q1 2026, an estimated $537K.
  • Victory Capital Management first reported a position in Regenxbio in Q3 2016 and held it in 22 quarters.
  • Victory Capital Management's Regenxbio position peaked at $4.56M in Q2 2018.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.